In both healthy donors and AML patients, double negative (DN) CD4-CD8- T cells showed the lowest percentages of DNAM-1+ cells independently of CD56 expression and CD4+CD56+ T cells the highest expression. This evidence concerns the gene CD8A and acute myeloid leukemia.